Vimarsana
Biggest News Aggregation in the World

Page 2 - Liso Cel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Liso Cel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Liso Cel Today - Breaking & Trending Today

CAR T-cells as Third-line and Beyond Therapy for FL - Vimarsana News

CAR T-cells as Third-line and Beyond Therapy for FL

Bijal Shah, MD, discusses recent data on CAR T-cell therapy as third-line and beyond treatment for FL.

Lisocabtagene Maraleucel in R/R MCL: Primary Analysis Results from the MCL Cohort of the Single-Arm, Multicenter, Seamless Design TRANSCEND NHL 001 Study - Vimarsana News

Lisocabtagene Maraleucel in R/R MCL: Primary Analysis Results from the MCL Cohort of the Single-Arm, Multicenter, Seamless Design TRANSCEND NHL 001 Study

Alexey Danilov, MD, PhD, reviews data from the TRANSCEND NHL 001 study investigating lisocabtagene maraleucel in patients with relapsed/refractory mantle cell lymphoma.

FDA Grants Priority Review to Liso-Cel for R/R Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Vimarsana News

FDA Grants Priority Review to Liso-Cel for R/R Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

The FDA has granted priority review to the supplemental biologics license application seeking approval to expand the indication of lisocabtagene maraleucel to include patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who had prior exposure to a BTK inhibitor and a BCL-2 inhibitor.

Utilizing Bispecific Treatment in Relapsed DLBCL Patients - Vimarsana News

Utilizing Bispecific Treatment in Relapsed DLBCL Patients

Dr Gordon discusses use of bispecifics for management of patients with relapsing DLBCL.

Source: ajmc.com
DLBCL Treatment in Elderly Patients with Multiple Comorbidities - Vimarsana News

DLBCL Treatment in Elderly Patients with Multiple Comorbidities

Treatment of DLBCL amid comorbidities in elderly patients is highlighted.

Source: ajmc.com